IBJNews

Aarden Pharmaceuticals chose Indianapolis over San Diego for headquarters

Back to TopCommentsE-mailPrintBookmark and Share
On The Beat Industry News In Brief

Overlooked in the Nov. 10 announcement that Aarden Pharmaceuticals would establish its headquarters here is that it considered San Diego, that sunnier and more renowned life sciences bastion.

“Essentially, some of the founders are located in San Diego and there was some original thought of the HQ being there,” Gary Noonan, president and CEO and one of just two employees of Aarden, told IBJ.

But thanks partly to a $500,000 grant from the Indiana Economic Development Corp.’s 21st Century Research and Technology Fund, and support from Indiana’s BioCrossroads life sciences initiative, principals “decided that locating it in Indianapolis would give Aarden a better chance of success.”

Academic co-founder is Zhong-Yin Zhang, chairman of the Department of Biochemistry and Molecular Biology at the Indiana University School of Medicine.

Zhang is also an expert in the field of protein tyrosine phosphatases. His research allowed for drugs to treat diseases such as tuberculosis. Aarden’s TB drug I-A09 is in pre-clinical development.

Work is also under way on drugs targeting diabetes, obesity, breast cancer, lupus and rheumatoid arthritis.

Many of the PTPs “were deemed undruggable,” Zhang said.

The firm has set up in offices along the Central Canal.

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT